Exemption

Comprehensive cancer centers

Retail Sales & Use Tax exemption · RCW 82.08.808; 82.12.808 · enacted 2005

All exemptions & deductions

Details

Citation
RCW 82.08.808; 82.12.808
Study reference
E1658-1
Tax type
Retail Sales & Use Tax
Preference type
Exemption
Category
Nonprofit
Year enacted
2005
End date
None scheduled

Fiscal impact (2024 study estimates)

Revenue if repealed — local ($M)
FY 2024: 0 · FY 2025: CTI · FY 2026: CTI · FY 2027: CTI
Revenue if repealed — state ($M)
FY 2024: 0 · FY 2025: CTI · FY 2026: CTI · FY 2027: CTI
Taxpayer savings — local ($M)
FY 2024: CTI · FY 2025: CTI · FY 2026: CTI · FY 2027: CTI
Taxpayer savings — state ($M)
FY 2024: CTI · FY 2025: CTI · FY 2026: CTI · FY 2027: CTI

CTI = confidential taxpayer information · D = unable to disclose

From the 2024 DOR Tax Exemption Study

82.08.808; 82.12.808 - Comprehensive cancer centers Description Sales of medical supplies, chemicals, or materials to a comprehensive cancer center are exempt from retail sales and use taxes. The exemption does not extend to the sale of construction materials, office equipment, building equipment, administrative supplies, or vehicles. Purpose To encourage cancer research by a comprehensive cancer center. Taxpayer ($ in millions): savings FY 2024 FY 2025 FY 2026 FY 2027 State Taxes CTI CTI CTI CTI Local Taxes CTI CTI CTI CTI Repeal of Repealing this exemption would increase revenues. exemption Potential ($ in millions): revenue gains FY 2024 FY 2025 FY 2026 FY 2027 from full repeal State Taxes $0.000 CTI CTI CTI Local Taxes $0.000 CTI CTI CTI Assumptions This exemption impacts fewer than three taxpayers; any impacts are confidential. Data Sources Financial statement of the business Additional Additional Information Information Category: Nonprofit Year Enacted: 2005 Primary Beneficiaries: Comprehensive cancer centers Taxpayer Count: Fewer than three Program Inconsistency: None evident JLARC Review: Expedited review completed in 2013 and 2021 2024 Tax Exemption Study Page 932

Does this apply to you?

This is reference data from the 2024 study — not advice, and 2025–26 legislation may have changed it. Three ways to go deeper: